Crossject

Crossject Société Anonyme develops needle-free injection systems in France. Its ZENEO platform is a needle-free, pre-filled, single-use auto-injector. The company offers formulations including Midazolam for epileptic seizures, Terbutaline for severe asthma attacks, Epinephrine for anaphylactic shock, Sumatriptan for migraine and cluster headaches, Hydrocortisone for acute adrenal crisis, and Methotrexate for rheumatoid arthritis. It is also developing ZEPIZURE, an emergency treatment for managing epileptic seizures. Crossject was incorporated in 2001 and is based in Dijon, France.